Zobrazeno 1 - 10
of 48
pro vyhledávání: '"David Kravetz"'
Autor:
David Kravetz
Publikováno v:
Cardiovascular Complications of Liver Disease ISBN: 9781315138817
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32ad9be8feb0c51e8a7646d1cc90160b
https://doi.org/10.1201/9781315138817-19
https://doi.org/10.1201/9781315138817-19
Autor:
Christine Perry, Ann Herrin, Samuel B. Ho, Sue Hadley, David Kravetz, Adrian Dollarhide, Ernesto Enrique, James Michelsen, Shannon K. Robinson, Laurie Carlson, Erik J. Groessl, Courtney Sanchez, Hilda Thorisdottir, Dan Montoya
Publikováno v:
Open Medicine Journal. 3:70-78
Background: Currently 4 million persons in the US have active hepatitis C virus (HCV) infection and most have never successfully completed antiviral treatment. Newer therapies herald potential for wider uptake and acceptance of treatment, but the num
Autor:
Samuel B. Ho, David Kravetz, Shannon K. Robinson, Eric Dieperink, Adrian Dollarhide, Erik J. Groessl
Publikováno v:
The American Journal of Gastroenterology. 103:1810-1823
The prevalence of hepatitis C virus (HCV) infection is higher among veterans than nonveterans, but only about 14% of all identified infected veterans have ever received antiviral therapy. High rates of comorbid psychiatric and substance use disorders
Autor:
David Kravetz
Publikováno v:
Journal of Clinical Gastroenterology. 41:S318-S322
Variceal rebleeding is a very frequent and severe complication in cirrhotic patients; therefore, its prevention should be mandatory. Lately several studies demonstrated that the rate of rebleeding was decreased by 40% and overall survival is improved
Autor:
N. Dominguez, A. Suarez, R. Terg, Julio Argonz, E. Fassio, David Kravetz, C. Vulcano, Alberto Muñoz, P. Salgado, Gustavo Romero, A. Bosco
Publikováno v:
Alimentary Pharmacology & Therapeutics. 24:601-611
SUMMARY Background After variceal bleeding, cirrhotic patients should receive secondary prophylaxis. Aim To compare nadolol plus 5-isosorbide mononitrate (5-ISMN) with endoscopic band ligation. The end points were rebleeding, treatment failure and de
Autor:
David Kravetz, Vikas Bhalla, Ravinder K. Mittal, James L. Puckett, Tarek Hassanein, Mary L. Krinsky, Jianmin Liu
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 288:G914-G919
We report our experience with an ultrasound system to measure esophageal varix pressure in an in vitro model. The ultrasound system consists of a 12.5 MHz frequency intraluminal ultrasound probe, a water infusion catheter, and a manometry catheter, a
Autor:
Alberto Muñoz, Julio Argonz, Ruben Terg, Marcelo Bildozola, Alejandro L. Suarez, Gustavo E. Romero, David Kravetz, Jacob Korula
Publikováno v:
American Journal of Gastroenterology. 95:1770-1775
It has been suggested that ascites is a risk factor for variceal bleeding. Recently, it has been demonstrated that total paracentesis decreases variceal pressure. However, no data are available showing the basal variceal pressure in patients with and
Autor:
Marcelo Bildozola, Julio Argonz, Alejandro L Suarez, Gustavo E. Romero, David Kravetz, Ruben Terg
Publikováno v:
Journal of Hepatology. 32:419-425
Terlipressin decreases portal pressure. However, its effects on variceal pressure have been poorly investigated. This study investigated the variceal, splanchnic and systemic hemodynamic effects of terlipressin.Twenty cirrhotic patients with esophage
Autor:
J. Valero, Julio Argonz, Alejandro L. Suarez, Gustavo E. Romero, David Kravetz, Monica Passamonti, Marcelo Bildozola, Ruben Terg
Publikováno v:
Gastrointestinal Endoscopy. 51:157-163
Background: The combination treatment of band ligation plus sclerotherapy has been proposed to hasten variceal eradication. The aim of this study was to assess the efficacy of band ligation alone versus band ligation plus sclerotherapy in the prevent
Autor:
Santiago J. Munoz, Kevin M. Korenblat, Howard Paul Monsour, Richard Gilroy, Marie Noëlle Pépin, Yuri Genyk, Andrea Duchini, David A. Sass, Khurram Jamil, Colin Swales, Obaid S. Shaikh, John R. Lake, Kris V. Kowdley, Zeid Kayali, Stevan A. Gonzalez, Alex S. Befeler, Joseph F. Buell, Florence Wong, Terry Box, Samuel H. Sigal, Victor Araya, Mark N. Wong, Michael B. Fallon, Sukru Emre, Adnan Said, Atif Zaman, Paul Y. Kwo, Paul Angulo, Fredric Regenstein, Maria Del Pilar Hernandez, Hugo E. Vargas, Eva Urtasun Sotil, Priya Grewal, David S. Barnes, Marco Olivera-Martinez, Tarek Hassanein, Juan A. Guerrero, Brendan M. McGuire, Eyob Feyssa, David S. Wolf, K. Rajender Reddy, Nathan J. Shores, R. Todd Frederick, Hany Elbeshbeshy, Stephen D. Zucker, Lorenzo Rossaro, Vishal C. Patel, Daniel Ganger, Arun J. Sanyal, Ram Subramanian, Fredric G. Regenstein, Charles D. Howell, Thomas D. Boyer, Jacqueline G. O'Leary, Nikroo Hashemi, Marlyn J. Mayo, Stephen Chris Pappas, Jasmohan S. Bajaj, Michael P. Curry, Michael K. Porayko, Rohit Satoskar, Madhavi Rudraraju, Kirti Shetty, Antonio Sanchez, K. Gautham Reddy, David Kravetz
Publikováno v:
Gastroenterology. 150:1579-1589.e2
Hepatorenal syndrome type 1 (HRS-1) in patients with cirrhosis and ascites is a functional, potentially reversible, form of acute kidney injury characterized by rapid (2 wk) and progressive deterioration of renal function. Terlipressin is a synthetic